DS
Daniel S. Lorrain
DELAYED 1 MONTH
Chief Scientific Officer
Contineum Therapeutics, Inc.
Filings
2
Companies
1
Latest
Jun 1, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
50
Contineum Therapeutics, Inc.
Daniel S. Lorrain
Chief Scientific Officer
Sale
$54.9K
4,170 sh
Jun 1 10:08 PM
Jun 1, 2026
50
Contineum Therapeutics, Inc.
Daniel S. Lorrain
Chief Scientific Officer
Sale
$54.7K
4,170 sh
May 1 9:42 PM
May 1, 2026